- Home
- FTHM vs CRIS Comparison
FTHM vs CRIS Comparison
Compare FTHM & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- CRIS
- Stock Information
- Founded
- FTHM 2010
- CRIS 2000
- Country
- FTHM United States
- CRIS United States
- Employees
- FTHM N/A
- CRIS N/A
- Industry
- FTHM Real Estate
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTHM Finance
- CRIS Health Care
- Exchange
- FTHM Nasdaq
- CRIS Nasdaq
- Market Cap
- FTHM 33.6M
- CRIS 21.3M
- IPO Year
- FTHM 2020
- CRIS 2000
- Fundamental
- Price
- FTHM $1.27
- CRIS $1.81
- Analyst Decision
- FTHM Buy
- CRIS Strong Buy
- Analyst Count
- FTHM 1
- CRIS 2
- Target Price
- FTHM $2.50
- CRIS $16.50
- AVG Volume (30 Days)
- FTHM 89.4K
- CRIS 177.3K
- Earning Date
- FTHM 08-11-2025
- CRIS 07-31-2025
- Dividend Yield
- FTHM N/A
- CRIS N/A
- EPS Growth
- FTHM N/A
- CRIS N/A
- EPS
- FTHM N/A
- CRIS N/A
- Revenue
- FTHM $357,816,000.00
- CRIS $11,202,000.00
- Revenue This Year
- FTHM $32.40
- CRIS N/A
- Revenue Next Year
- FTHM $18.04
- CRIS $10.67
- P/E Ratio
- FTHM N/A
- CRIS N/A
- Revenue Growth
- FTHM 5.80
- CRIS 14.17
- 52 Week Low
- FTHM $0.65
- CRIS $1.02
- 52 Week High
- FTHM $3.37
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- FTHM 53.30
- CRIS 43.58
- Support Level
- FTHM $1.27
- CRIS $1.50
- Resistance Level
- FTHM $1.39
- CRIS $1.98
- Average True Range (ATR)
- FTHM 0.10
- CRIS 0.19
- MACD
- FTHM 0.01
- CRIS -0.05
- Stochastic Oscillator
- FTHM 61.54
- CRIS 43.88
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.